Peculiarities of IGF family in the lung cancer

G. E. Sagindikova, E. A. Kogan, G. Jaques (Moscow, Russia; Marburg, Germany)

Source: Annual Congress 2001 - Lung cancer biology
Session: Lung cancer biology
Session type: Thematic Poster Session
Number: 1603
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. E. Sagindikova, E. A. Kogan, G. Jaques (Moscow, Russia; Marburg, Germany). Peculiarities of IGF family in the lung cancer. Eur Respir J 2001; 16: Suppl. 31, 1603

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung cancer and family history of cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 124s
Year: 2006

Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer
Source: Eur Respir J 2005; 25: 329-335
Year: 2005



Prognostic significance of epidermal growth factor receptor expression in nonsmall cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 72s
Year: 2002

Clinical features associated with epidermal growth factor receptor and K-RAS gene mutations in non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 811s
Year: 2006

Expression of sex hormone receptors in non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004

The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer
Source: Eur Respir Rev 2010 19: 186-196
Year: 2010



Epidermal growth factor receptor and related biomarkers evaluated by immunohistochemistry in patients with resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 669s
Year: 2007

Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung cancer and its correlation with survival
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009


PP138 – Regulation of PA200 in lung cancer
Source: ERS Lung Science Conference 2021
Year: 2021

Regulation of PA200 in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer
Source: Eur Respir J 2011; 37: 183-193
Year: 2011



Epidermal growth factor receptor mutation status in advanced non-small cell lung cancer: A single institution experience
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012

Diverse effects of PAI-1 proteins on lung and prostate cancer cell invasion
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011


Relationship between Cancer-associated fibroblast and programmed death ligand 1 expression in non-small cell lung cancer
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006


Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009